GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
39.13
+0.91 (2.38%)
At close: Aug 13, 2025, 4:00 PM
38.79
-0.34 (-0.87%)
Pre-market: Aug 14, 2025, 9:18 AM EDT
GSK Market Cap
GSK has a market cap or net worth of $78.50 billion as of August 14, 2025. Its market cap has decreased by -2.96% in one year.
Market Cap
78.50B
Enterprise Value
96.55B
1-Year Change
-2.96%
Ranking
Category
Stock Price
$39.13
Market Cap Chart
Since December 1, 1998, GSK's market cap has decreased from $159.34B to $78.50B, a decrease of -50.73%. That is a compound annual growth rate of -2.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 79.49B | 15.93% |
| Dec 31, 2024 | 68.57B | -8.74% |
| Dec 29, 2023 | 75.14B | 6.12% |
| Dec 30, 2022 | 70.81B | -35.88% |
| Dec 31, 2021 | 110.43B | 20.28% |
| Dec 31, 2020 | 91.81B | -21.29% |
| Dec 31, 2019 | 116.64B | 23.14% |
| Dec 31, 2018 | 94.72B | 8.77% |
| Dec 29, 2017 | 87.08B | -7.13% |
| Dec 30, 2016 | 93.77B | -4.44% |
| Dec 31, 2015 | 98.13B | -5.42% |
| Dec 31, 2014 | 103.75B | -21.06% |
| Dec 31, 2013 | 131.43B | 19.76% |
| Dec 31, 2012 | 109.74B | -7.43% |
| Dec 30, 2011 | 118.55B | 16.46% |
| Dec 31, 2010 | 101.79B | -7.10% |
| Dec 31, 2009 | 109.58B | 17.51% |
| Dec 31, 2008 | 93.25B | -31.55% |
| Dec 31, 2007 | 136.24B | -6.62% |
| Dec 29, 2006 | 145.90B | 52.77% |
| Dec 31, 2002 | 95.50B | -24.81% |
| Dec 31, 2001 | 127.01B | -11.04% |
| Dec 29, 2000 | 142.77B | 0.22% |
| Dec 31, 1999 | 142.45B | -19.60% |
| Dec 31, 1998 | 177.18B | 11.20% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |